A
Arlene Reynolds
Researcher at Health Protection Scotland
Publications - 39
Citations - 1706
Arlene Reynolds is an academic researcher from Health Protection Scotland. The author has contributed to research in topics: Vaccination & Population. The author has an hindex of 20, co-authored 37 publications receiving 1300 citations.
Papers
More filters
Journal ArticleDOI
Virus–virus interactions impact the population dynamics of influenza and the common cold
Sema Nickbakhsh,Colette Mair,Louise Matthews,Richard Reeve,Paul C. D. Johnson,Fiona Thorburn,Beatrix von Wissmann,Arlene Reynolds,James McMenamin,Rory Gunson,Pablo R. Murcia +10 more
TL;DR: Using computer simulations, it is found that very short-lived interferences may explain why common cold infections are less frequent during flu seasons and transient immune-mediated interference can cause a relatively ubiquitous common cold-like virus to diminish during peak activity of a seasonal virus.
Journal Article
Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-ofseason results
Richard Pebody,Fiona Warburton,Joanna Ellis,Nick Andrews,Alison Potts,Simon Cottrell,Jillian Johnston,Arlene Reynolds,Rory Gunson,Catherine Thompson,Monica Galiano,Chris Robertson,Rachel Byford,Naomh Gallagher,Mary Sinnathamby,Ivelina Yonova,Sameera Pathirannehelage,Matthew Donati,Catherine Moore,S de Lusignan,Jim McMenamin,Maria Zambon +21 more
TL;DR: Estimates demonstrate moderate to good levels of protection, particularly against influenza B in children, but relatively less against influenza A(H1N1)pdm09, which provides reassurance for the UK to continue its influenza immunisation programme planned for 2016/17.
Journal ArticleDOI
Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results
Richard Pebody,Fiona Warburton,Joanna Ellis,Nick Andrews,Alison Potts,Simon Cottrell,Jillian Johnston,Arlene Reynolds,Rory Gunson,Catherine Thompson,Monica Galiano,Chris Robertson,Rachel Byford,Naomh Gallagher,Mary Sinnathamby,Ivelina Yonova,Ivelina Yonova,Sameera Pathirannehelage,Matthew Donati,Catherine Moore,Simon de Lusignan,Simon de Lusignan,Jim McMenamin,Maria Zambon +23 more
TL;DR: The United Kingdom (UK) is in the third season of introducing universal paediatric influenza vaccination with a quadrivalent live attenuated influenza vaccine (LAIV) as mentioned in this paper, which was initially dominated by influenza A(H1N1)pdm09 and then influenza of B/Victoria lineage, not contained in that season's adult trivalent inactivated influenza vaccine.
Journal ArticleDOI
Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017
Lasse S Vestergaard,Jens Nielsen,Tyra Grove Krause,Laura Espenhain,Katrien Tersago,Natalia Bustos Sierra,Gleb Denissov,Kaire Innos,M. J. Virtanen,Anne Fouillet,Theodore Lytras,Anna Páldy,János Bobvos,Lisa Domegan,Joan O'Donnell,Matteo Scortichini,Annamaria De Martino,Kathleen England,Neville Calleja,Liselotte van Asten,Teirlinck Ac,Ragnhild Tønnessen,Richard A. White,Susana Silva,Ana Paula Rodrigues,Amparo Larrauri,Inmaculada León,Ahmed Farah,Christoph Junker,Mary Sinnathamby,Richard Pebody,Arlene Reynolds,Jennifer Bishop,Diane Gross,Cornelia Adlhoch,Pasi Penttinen,Kåre Mølbak +36 more
TL;DR: The pattern was similar to the last major influenza A(H3N2) season in 2014/15 in Europe, although starting earlier in line with the early influenza season start, and cold weather snaps contributed in some countries.
Journal ArticleDOI
Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results.
Richard Pebody,Fiona Warburton,Nick Andrews,Joanna Ellis,Beatrix von Wissmann,Chris Robertson,Ivelina Yonova,Simon Cottrell,Naomh Gallagher,Helen K. Green,Catherine Thompson,Monica Galiano,Diogo F P Marques,Rory Gunson,Arlene Reynolds,Catherine Moore,David Mullett,Sameera Pathirannehelage,Matthew Donati,Jillian Johnston,Simon de Lusignan,Jim McMenamin,Maria Zambon +22 more
TL;DR: Although the VE against influenza A(H3N2) infection was low, there was still evidence of significant protection, together with moderate, significant protection against drifted circulating influenza B viruses.